New antithrombotic strategies for resistant thrombotic processes.

about

New Antithrombotic Drugs of Coronary Artery Disease.Thrombin functions as an inflammatory mediator through activation of its receptor.

P2860

Q41720782-9BB61D12-9C39-4264-BD0B-51624D11A7D2 Q41879963-70F8AE69-1A7A-401B-B52D-3FCD25712B11

P2860

New antithrombotic strategies for resistant thrombotic processes.

Item

http://www.wikidata.org/entity/Q40727618

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年学术文章

@wuu

1994年学术文章

@zh-cn

1994年学术文章

@zh-hans

1994年学术文章

@zh-my

1994年学术文章

@zh-sg

1994年學術文章

@yue

1994年學術文章

@zh

1994年學術文章

@zh-hant

name

New antithrombotic strategies for resistant thrombotic processes.

@en

type

Item

label

New antithrombotic strategies for resistant thrombotic processes.

@en

prefLabel

New antithrombotic strategies for resistant thrombotic processes.

@en

P1476

New antithrombotic strategies for resistant thrombotic processes.

@en

P2093

Harker LA

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

Characterization of a functional thrombin receptor. Issues and opportunities

The structure of a complex of recombinant hirudin and human alpha-thrombin

Integrins: versatility, modulation, and signaling in cell adhesion

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

P304

3-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1552-4604.1994.TB03960.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1994-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8132848

http://www.w3.org/2001/XMLSchema#string

New antithrombotic strategies for resistant thrombotic processes.

about

P2860

P2860

New antithrombotic strategies for resistant thrombotic processes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698